Biologics are drugs in the form of genetically engineered proteins derivative of human genes. The biologics can be composed of proteins, sugars, or nucleic acids or complex combinations of these substances, or may be living entities such as cells and tissues. Advanced biotechnology techniques and complex processes are used to manufacture biologics, as they are important for biomedical research.
The "Global Biologics Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the biologics market with detailed market segmentation by product, application, and geography. The report provides key statistics on the market status of the leading biologics market players and offers key trends and opportunities in the market.
- Based on product, the global biologics market is segmented into monoclonal antibodies, vaccines, recombinant hormones/proteins, cellular-based biologics, gene-based biologics, other products.
- On the basis of application, the market is segmented into cancer, infectious diseases, autoimmune diseases, other applications.
- Rise in the prevalence of chronic diseases
- Growing demand for innovative therapies
- Loss of patent exclusivity of the leading biologic drugs
- Stringent Regulatory Process
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The biologics market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the market in these regions.
IMPACT OF COVID-19 ON BIOLOGICS MARKET
There has been a huge demand for biologics during the pandemic, which may drive the market growth. For instance, in May 2020, the National Research Council of Canada and CanSino Biologics collaborated for the clinical development of a COVID-19 vaccine in Canada. Over the past few years, the pharmaceutical industry has been the rise of biologics. As this exciting sector grows, it is having a significant impact on the pharmaceutical industry. Thus, extensive research and development activities taking place on biologics for the treatment of COVID-19 are expected to drive the growth of the biologics market in coming years.
The report covers key developments in the biologics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from biologics market are anticipated to lucrative growth opportunities in the future with the rising demand for biologics market in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the biologics market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
- AbbVie Inc.
- Amgen Inc.
- Eli Lilly and Company
- F. Hoffmann-La Roche AG
- GlaxoSmithKline PLC
- Johnson & Johnson
- Merck & Co.
- Novo Nordisk AS
- Pfizer Inc.
- Sanofi SA
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.